tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
LENZ
LENZ Therapeutics
RESEARCH TOOLSreports
Want to see LENZ full AI Analyst Report?

LENZ Therapeutics (LENZ) Stock Forecast & Price Target

425 Followers
See the Price Targets and Ratings of:

LENZ Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
4 Buy
2 Hold
0 Sell
Based on 6 analysts giving stock ratings to
LENZ
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

LENZ Stock 12 Month Forecast

Average Price Target

$24.40
▲(407.28% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for LENZ Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $60.00 and a low forecast of $7.00. The average price target represents a 407.28% change from the last price of $4.81.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","61":"$61","18.25":"$18.25","32.5":"$32.5","46.75":"$46.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":60,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$60.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,18.25,32.5,46.75,61],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.23,9.443076923076923,13.656153846153845,17.869230769230768,22.08230769230769,26.295384615384613,30.508461538461535,34.72153846153846,38.934615384615384,43.14769230769231,47.36076923076922,51.57384615384615,55.786923076923074,{"y":60,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.23,6.704615384615385,8.17923076923077,9.653846153846153,11.128461538461538,12.603076923076923,14.077692307692306,15.552307692307691,17.026923076923076,18.50153846153846,19.976153846153846,21.45076923076923,22.925384615384612,{"y":24.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.23,5.366153846153846,5.502307692307693,5.638461538461539,5.774615384615385,5.910769230769231,6.046923076923077,6.183076923076923,6.319230769230769,6.455384615384616,6.591538461538462,6.727692307692308,6.863846153846154,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.25,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.05,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.72,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.4,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.3,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.68,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.35,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.88,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.44,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.79,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.3,"date":1785531600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.23,"date":1788210000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$60.00Average Price Target$24.40Lowest Price Target$7.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on LENZ
Yigal Nochomovitz
Citi
Citi
$20→$10
Buy
107.90%
Upside
Reiterated
08/13/26
Analyst Maintains Buy on LENZ, Cuts VIZZ Price Target to $10 While Highlighting Strong Patient Persistence and Long-Term Upside
Bank of America Securities Analyst forecast on LENZ
Jason Gerberry
Bank of America Securities
Bank of America Securities
$7
Hold
45.53%
Upside
Downgraded
08/12/26
Jason Gerberry Maintains Hold on LENZ Therapeutics as Weak VIZZ Launch Spurs Major Sales Forecast Cuts
H.C. Wainwright Analyst forecast on LENZ
Matthew Caufield
H.C. Wainwright
H.C. Wainwright
$38
Buy
690.02%
Upside
Reiterated
08/12/26
Caufield Reiterates Buy on VIZZ as Strong Early Adoption and Expanding Access Channels Support Unchanged $38 Price Target
Piper Sandler Analyst forecast on LENZ
Biren Amin
Piper Sandler
Piper Sandler
$12→$7
Hold
45.53%
Upside
Reiterated
08/12/26
Piper Sandler Sticks to Its Hold Rating for LENZ Therapeutics (LENZ)
TD Cowen Analyst forecast on LENZ
Stacy Ku
TD Cowen
TD Cowen
$60
Buy
1147.40%
Upside
Assigned
08/12/26
Analysts Conflicted on These Healthcare Names: C4 Therapeutics (NASDAQ: CCCC), Codexis (NASDAQ: CDXS) and LENZ Therapeutics (NASDAQ: LENZ)
William Blair Analyst forecast on LENZ
Lachlan Hanbury Brown
William Blair
William Blair
―
Buy
―
Reiterated
08/12/26
Analyst Maintains Buy on LENZ as VIZZ Adoption, Prescriber Engagement and Patient Refill Trends Support Long-Term Commercial Franchise Growth
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on LENZ
Yigal Nochomovitz
Citi
Citi
$20→$10
Buy
107.90%
Upside
Reiterated
08/13/26
Analyst Maintains Buy on LENZ, Cuts VIZZ Price Target to $10 While Highlighting Strong Patient Persistence and Long-Term Upside
Bank of America Securities Analyst forecast on LENZ
Jason Gerberry
Bank of America Securities
Bank of America Securities
$7
Hold
45.53%
Upside
Downgraded
08/12/26
Jason Gerberry Maintains Hold on LENZ Therapeutics as Weak VIZZ Launch Spurs Major Sales Forecast Cuts
H.C. Wainwright Analyst forecast on LENZ
Matthew Caufield
H.C. Wainwright
H.C. Wainwright
$38
Buy
690.02%
Upside
Reiterated
08/12/26
Caufield Reiterates Buy on VIZZ as Strong Early Adoption and Expanding Access Channels Support Unchanged $38 Price Target
Piper Sandler Analyst forecast on LENZ
Biren Amin
Piper Sandler
Piper Sandler
$12→$7
Hold
45.53%
Upside
Reiterated
08/12/26
Piper Sandler Sticks to Its Hold Rating for LENZ Therapeutics (LENZ)
TD Cowen Analyst forecast on LENZ
Stacy Ku
TD Cowen
TD Cowen
$60
Buy
1147.40%
Upside
Assigned
08/12/26
Analysts Conflicted on These Healthcare Names: C4 Therapeutics (NASDAQ: CCCC), Codexis (NASDAQ: CDXS) and LENZ Therapeutics (NASDAQ: LENZ)
William Blair Analyst forecast on LENZ
Lachlan Hanbury Brown
William Blair
William Blair
―
Buy
―
Reiterated
08/12/26
Analyst Maintains Buy on LENZ as VIZZ Adoption, Prescriber Engagement and Patient Refill Trends Support Long-Term Commercial Franchise Growth
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
STOKStoke Therapeutics
AXGNAxoGen
JAZZJazz Pharmaceuticals
PTGXProtagonist Therapeutics
CABACabaletta Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering LENZ Therapeutics

3 Months
Lachlan Hanbury BrownWilliam Blair
Success Rate
8/15 ratings generated profit
53%
Average Return
-5.97%
Copying Lachlan Hanbury Brown's trades and holding each position for 3 Months would result in 53.33% of your transactions generating a profit, with an average return of -5.97% per trade.
1 Year
Lachlan Hanbury BrownWilliam Blair
Success Rate
3/15 ratings generated profit
20%
Average Return
-47.30%
Copying Lachlan Hanbury Brown's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -47.30% per trade.
2 Years
Lachlan Hanbury BrownWilliam Blair
Success Rate
3/15 ratings generated profit
20%
Average Return
-50.79%
Copying Lachlan Hanbury Brown's trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -50.79% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LENZ Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
11
7
5
4
4
Buy
4
3
3
3
2
Hold
1
1
2
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
11
10
10
9
In the current month, LENZ has received 6 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. LENZ average Analyst price target in the past 3 months is 24.40.
Each month's total comprises the sum of three months' worth of ratings.

LENZ Financial Forecast

LENZ Earnings Forecast

Next quarter’s earnings estimate for LENZ is -$0.93 with a range of -$1.07 to -$0.66. The previous quarter’s EPS was -$1.02. LENZ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year LENZ has Performed in-line its overall industry.
Next quarter’s earnings estimate for LENZ is -$0.93 with a range of -$1.07 to -$0.66. The previous quarter’s EPS was -$1.02. LENZ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year LENZ has Performed in-line its overall industry.

LENZ Sales Forecast

Next quarter’s sales forecast for LENZ is $4.49M with a range of $2.20M to $9.20M. The previous quarter’s sales results were $5.49M. LENZ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year LENZ has Performed in-line its overall industry.
Next quarter’s sales forecast for LENZ is $4.49M with a range of $2.20M to $9.20M. The previous quarter’s sales results were $5.49M. LENZ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year LENZ has Performed in-line its overall industry.

LENZ Stock Forecast FAQ

What is LENZ’s average 12-month price target, according to analysts?
Based on analyst ratings, LENZ Therapeutics’s 12-month average price target is 24.40.
    What is LENZ’s upside potential, based on the analysts’ average price target?
    LENZ Therapeutics has 407.28% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is LENZ a Buy, Sell or Hold?
          LENZ Therapeutics has a consensus rating of Moderate Buy which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
            What is LENZ Therapeutics’s price target?
            The average price target for LENZ Therapeutics is 24.40. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $60.00 ,the lowest forecast is $7.00. The average price target represents 407.28% Increase from the current price of $4.81.
              What do analysts say about LENZ Therapeutics?
              LENZ Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of LENZ?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.